Cancer drug costs discussed

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1460, 2004-01, pp. : 3-3

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cancer drug costs prove tough for both patients and physicians

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 558, 2008-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Characteristics of drug-related problems discussed by hospital pharmacists in multidisciplinary teams

By Blix Hege Viktil Kirsten Moger Tron Reikvam Åsmund

Pharmacy World and Science, Vol. 28, Iss. 3, 2006-06 ,pp. : 152-158

Springer Publishing Company

Access to resources Recommend Favorite

Calculating cancer costs in the EU

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 666, 2012-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

RCTs rarely mention drug costs

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 612, 2010-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Cancer care costs at "crisis" point

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 639, 2011-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite